Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 12, 2025
Response to Letter to the Editor
Chun-Ming Hong, Chun-Jen Liu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
March 12, 2026
Response to letter to the editor
Chun-Ming Hong, Chun-Jen Liu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 31, 2016
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response
Chun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, et al.
BMC Gastroenterology
|
November 17, 2020
Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients
Chun-Ta Huang, Chun-Ming Hong, Yi-Ju Tsai, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
December 18, 2023
Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B
Hao-Che Chang, Tung-Hung Su, Yu-Tsung Huang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 15, 2018
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, et al.
Journal of Gastroenterology and Hepatology
|
January 30, 2019
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
Chen-Hua Liu, Tung-Hung Su, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology
|
August 2, 2017
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Plos One
|
December 22, 2018
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Gastroenterology
|
January 15, 2023
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels
Tai-Chung Tseng, Chieh Chiang, Chun-Jen Liu, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 12, 2025
Response to Letter to the Editor
Chun-Ming Hong, Chun-Jen Liu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
March 12, 2026
Response to letter to the editor
Chun-Ming Hong, Chun-Jen Liu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 31, 2016
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response
Chun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, et al.
BMC Gastroenterology
|
November 17, 2020
Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients
Chun-Ta Huang, Chun-Ming Hong, Yi-Ju Tsai, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
December 18, 2023
Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B
Hao-Che Chang, Tung-Hung Su, Yu-Tsung Huang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 15, 2018
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, et al.
Journal of Gastroenterology and Hepatology
|
January 30, 2019
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
Chen-Hua Liu, Tung-Hung Su, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology
|
August 2, 2017
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Plos One
|
December 22, 2018
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Gastroenterology
|
January 15, 2023
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels
Tai-Chung Tseng, Chieh Chiang, Chun-Jen Liu, et al.
Page
of 4